Feb 28 |
Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)
|
Feb 16 |
Palatin Technologies, Inc. (AMEX:PTN) Q2 2024 Earnings Call Transcript
|
Feb 16 |
Q2 2024 Palatin Technologies Inc Earnings Call
|
Feb 15 |
Palatin Technologies, Inc. 2024 Q1 - Results - Earnings Call Presentation
|
Feb 15 |
Palatin Technologies, Inc. (PTN) Q2 2024 Earnings Call Transcript
|
Feb 15 |
Palatin Tech GAAP EPS of -$0.56 misses by $0.23, revenue of $2.03M beats by $0.27M
|
Feb 15 |
Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
|
Feb 9 |
Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024
|
Feb 5 |
Palatin Announces Database Lock for PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)
|
Feb 1 |
Palatin Announces Closing of $10 Million Registered Direct Offering
|